Role of CoQ10 and IGFBP-1 in Obese Male Patients with Diabetic Mellitus Type II
DOI:
https://doi.org/10.37506/ijfmt.v15i1.13731Keywords:
CoQ10, Obese patients, Diabetic Mellitus Type 2, IFG.Abstract
Study the role of CoQ10 and IGFBP-1 in obese male patients with diabetic mellitus type 2. ELISA method
was used to assay Serum CoQ10 and IGFBP-1. Blood was taken with drawn sample from 30 obese normal
patients with age range (40-60) years, 30 diabetic patients with age range (40-60) years at duration of disease
(1-5) years and 30 normal healthy patients. The mean difference between T2DM according to CoQ10
(12.5±1.1) was decreased than the mean of IFG (21.8±3.2) (P 0.002) and the mean difference between
T2DM according to IGFBPs (0.65±0.06) was decreased than the mean of IFG (3.2±0.3) (P 0.000). While
no significant difference between mean age of DM2 patients (55.5±1.06), and IFG (55.6±0.9) (p 0.90), no
significant difference between mean BMI of DM2 patients (27.7±0.8), and IFG (27.8±0.5) (p 0.94). there
were significant differences in DM and IFG obese groups (G1 and G2) according to age (51.66 ±2.10,
51.80±1.16) P (0.02), however, there were significant differences between DM and IFG in Normal weight
groups (G5 and G6) according to age (59.93±0.94, 51.13±1.80) P (0.00), while no significant differences
between DM and IFG in Over weight groups (G3 and G4) according to age (54.93±1.17, 58.00±1.73) p(0.21),
there were significant differences between DM2 and IFG in obese groups (G1 and G2) according to BMI
(33.70±1.20, 31.11±0.37) P (0.01), ), no significant difference between overweight (G3 and G4) according
to BMI (27.72±0.30, 27.52±0.34) P(0.66), and no significant difference between normal weight (G5 and G6)
according to BMI (21.84±0.45, 21.53±0.50) P(0.65). There were significant differences between DM and
IFG in obese groups (G1 and G2) according to CoQ10 (7.2±0.4, 4.9±0.4) P (0.002), and IGFBP (0.3±0.02,
1.2±0.19) P (0.005).
Published
How to Cite
Issue
Section

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Re use and mixing of content policy- We follow Creative Commons Licence Policy. We follow CC BY. Please refer below for all details
https://creativecommons.org/licenses/
CC BY
This license lets others distribute, remix, adapt, and build upon our work, even commercially, as long as they credit us for the original creation.
- The journal allows readers to read, download, copy, distribute, print, search, or link to the full texts of its articles and allow readers to use them for any other lawful purpose.
- The journal allows the author(s) to hold the copyright without restrictions.
- The journal allows the author(s) to retain publishing rights without restrictions